• Jump to main navigation
  • Jump to content
U of U Health
  • Billing & Insurance
  • MyChart
Search
  • Find A U of U Health Doctor
  • All U of U Health Services
  • All U of U Health Locations
  • For All U of U Health Patients & Visitors
    • Patient Services
      • Questions About Your Bill?
      • Urgent Care
      • Where to Stay
      • Patients & Family Services
      • Clinical Trials
    • University of Utah Hospital
      • University of Utah Hospital
      • Staying at the Hospital
      • Parking & Valet
      • Looking for Another Location?
    • General Questions
      • 801-581-2668
      • Find an Interpreter
      • About U of U Health
  • Billing & Insurance
  • MyChart
  • Search

Yazan Abou-Ismail, MD

  • Clinical Information
  • Academic Information
  • Clinical Trials
  • Patient Resources
  • Videos & News
No Rating Available?
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
19 4.9 out of 5 Patient Rating

Languages Spoken: Arabic, English

Yazan Abou-Ismail, MD (Mouhamed Yazan Abou-Ismail) is an Assistant Professor of Medicine at the Division of Hematology and Hematologic Malignancies. He specializes in treating non-malignant hematologic disorders, with special clinical interest in disorders of hemostasis and thrombosis, in which he has authored many peer-reviewed publications. Dr. Abou-Ismail's clinical and research interests include thrombotic microangiopathies such thrombotic thrombocytopenic purpura, immune-mediated disorders of coagulation, myeloproliferative neoplasms, as well as transgender hematology. Dr. Abou-Ismail earned his medical degree from Weill Cornell Medicine in Doha, Qatar in 2014, and then completed three years of Internal Medicine residency training at Rochester General Hospital in Rochester, New York. Afterwards, he completed three years of Hematology and Oncology fellowship training at Case Western Reserve University, in Cleveland, OH, where he was the recipient of the 2018 Harris Foundation award for hematology fellows.

Clinical Locations

Huntsman Cancer Hospital
Hematology Clinic

1950 Circle of Hope
Salt Lake City, UT  84112
Map

Specialties

  • Hematology/BMT

Board Certification and Academic Information

Academic Departments Internal Medicine - Assistant Professor (Clinical)
Academic Divisions Hematology/BMT
Board Certification American Board of Internal Medicine
American Board of Internal Medicine (Sub: Hematology)

Patient Rating

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Learn About Our Survey

Likelihood of recommending care provider

4.9/ 5

Care provider's explanation of condition/problem

4.9/ 5

Care provider's effort to include me in decisions

4.9/ 5

Wait time at clinic

4.7/ 5

Care provider's concern for questions & worries

4.9/ 5

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

UofU Patient November 21, 2022
Huntsman Cancer Institute

5 out of 5 stars

Dr. Abou-Ismail was amazing! He was so kind and caring. He took the time to explain my condition and the possible causes. He gave me several opportunities to ask questions and never made me feel like a burden on his time. I've been to several doctors recently and he was by far my favorite. I want to take him with me to all my future appointments so he can reassure me when the other doctors give me a diagnosis and then rush to their next appointment. He Is amazing! You are so lucky to have this provider at your institution!

UofU Patient October 04, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Both the physician assistant and dr. Listened to my concerns and explained things in layman's terms.

UofU Patient August 01, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Very grateful to be in Dr. Abou-Ismail's care.

UofU Patient July 04, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Friendly and clear

UofU Patient June 11, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Excellent caring staff. Dr. Abou-Ismail cared about my concerns, and wanted to make sure he answered all of my questions. Was not rushed at all.

UofU Patient March 14, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Very good

UofU Patient March 09, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

I'm def never going to see a different doc there unless I have to. He's been amazing!

UofU Patient March 07, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Good bedside manner

UofU Patient January 31, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr. Abou-Ismail is an excellent listener and explainer.

UofU Patient January 31, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Extremely pleased with entire process

UofU Patient January 17, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr Abou-Ismail is a lovely person, knowledgable and friendly. MA Michael also great.

UofU Patient December 20, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Wants to further evaluate possible diagnosis thru more lab work

UofU Patient November 08, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Very good

UofU Patient October 11, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Overall, I had a great experience with this Dr.

UofU Patient September 23, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

What a great doctor! This was one of the best doctor consultations I can remember. He arrived promptly, was professional and empathetic, courteous and respectful throughout the exam. He walked me through everything - tests ordered, medical history, any questions and demystified the science. His follow up was quick, thorough and gave clear answers and direction. I wish there were more doctors like Dr. Abou-Ismail.

UofU Patient August 25, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Could have used a little more info on the medical name for the infusion and why he chose that drug.over others on the market

UofU Patient August 24, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

I have always felt like the doctor truly cared about me. Felt like he took his time and explained everything and gave options to proceed. Very kind and caring!

UofU Patient May 17, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

one of the best experiences I have EVER had with a doctor at the U of U or at any time. He is a gem and should be head of a training experience ASAP!

UofU Patient February 03, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

good

Yazan Abou-Ismail, MD (Mouhamed Yazan Abou-Ismail) is an Assistant Professor of Medicine at the Division of Hematology and Hematologic Malignancies. He specializes in treating non-malignant hematologic disorders, with special clinical interest in disorders of hemostasis and thrombosis, in which he has authored many peer-reviewed publications. Dr. Abou-Ismail's clinical and research interests include thrombotic microangiopathies such thrombotic thrombocytopenic purpura, immune-mediated disorders of coagulation, myeloproliferative neoplasms, as well as transgender hematology. Dr. Abou-Ismail earned his medical degree from Weill Cornell Medicine in Doha, Qatar in 2014, and then completed three years of Internal Medicine residency training at Rochester General Hospital in Rochester, New York. Afterwards, he completed three years of Hematology and Oncology fellowship training at Case Western Reserve University, in Cleveland, OH, where he was the recipient of the 2018 Harris Foundation award for hematology fellows.

Academic Locations

Huntsman Cancer Hospital

801-585-3229

1950 Circle of Hope
Division of Hematology, Suite 4126
Salt Lake City, UT  84112

Board Certification and Academic Information

Academic Departments Internal Medicine - Assistant Professor (Clinical)
Academic Divisions Hematology/BMT
Board Certification American Board of Internal Medicine
American Board of Internal Medicine (Sub: Hematology)

Education History

Fellowship Case Western Reserve University
Hematology & Oncology
Fellow, 2020
Residency Rochester General Hospital
Internal Medicine
Resident, 2017
Professional Medical Weill Cornell Medical College in Qatar
Medicine
M.D., 2014
Doctoral Training Weill Cornell Medical College in Qatar
Premedical Program
, 2010

Selected Publications - Journal Articles

Journal Article

  1. Lim MY, Abou-Ismail MY, Branch DW (2022). Differentiating and Managing Rare Thrombotic Microangiopathies During Pregnancy and Postpartum. Obstet Gynecol, 141(1), 85-108.
  2. Kanack AJ, Jones CG, Singh B, Leger RR, Splinter NP, Heikal NM, Pruthi RK, Chen D, George G, Abou-Ismail MY, Wool GD, Gundabolu K, Padmanabhan A (2022). Off-the-shelf cryopreserved platelets for the detection of HIT and VITT antibodies. Blood, 140(25), 2722-2729.
  3. Abou-Ismail MY, James PD, Flood VH, Connell NT (2022). Beyond the guidelines: how we approach challenging scenarios in the diagnosis and management of von Willebrand disease. J Thromb Haemost.
  4. Kanack A, Bayas A, George G, Abou-Ismail MY, Singh B, Kohlhagen M, Splinter N, Christ M, Naumann M, Moser KA, Smock KJ, Grazioli A, Wen R, Wang D, Murray DL, Padmanabhan A (2022). Monoclonal and oligoclonal anti-Platelet Factor 4 antibodies mediate VITT. Blood, 140(1), 73-77.
  5. Abou-Ismail MY, Kanack A, Splinter N, Smock KJ, Moser K, Padmanabhan A (2022). Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT. Blood Adv, 6, 5327-5329.
  6. Abou-Ismail MY, Fraser R, Allbee-Johnson M, Metheny L 3rd, Ravi G, Ahn KW, Bhatt NS, Lazarus HM, de Lima M, El Jurdy N, Hematti P, Beitinjaneh AM, Nishihori T, Badawy SM, Sharma A, Pasquini MC, Savani BN, Sorror ML, Stadtmauer EA, Chhabra S (2022). Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation? Br J Haematol, 197, 326-338.
  7. Kanack AJ, Singh B, George G, Gundabolu K, Koepsell SA, Abou-Ismail MY, Moser KA, Smock KJ, Green D, Major A, Chan CW, Wool GD, Reding M, Ashrani AA, Bayas A, Grill DE, Padmanabhan A (2022). Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies. Am J Hematol, 97, 519-526.
  8. Abou-Ismail MY, Connell NT (2021). How to manage bleeding disorders in aging patients needing surgery. Hematology Am Soc Hematol Educ Program, 2021(1), 529-535.
  9. Abou-Ismail MY, Prchal JT, Deininger MW, Parker CJ, Lim MY (2021). Anticoagulation management post-transjugular intrahepatic portosystemic shunt in portal hypertension associated with myeloproliferative neoplasms. Blood Coagul Fibrinolysis, 32, 578-583.
  10. Abou-Ismail MY, Ravi G, Fu P, Cao S, Vuyyala S, Caimi P, Kolk M, Ferrari N, Boughan K, Cooper B, Gallogly M, Otegbeye F, Tomlinson B, de Lima M, Metheny L (2020). History of drug use in allogeneic hematopoietic cell transplant recipients. Bone Marrow Transplant, 56(3), 581-585.
  11. Abou-Ismail MY, Rodgers GM, Bray PF, Lim MY (2021). Acquired von Willebrand syndrome in monoclonal gammopathy - A scoping review on hemostatic management. Res Pract Thromb Haemost, 5(2), 356-365.
  12. Abou-Ismail MY, Arafah Y, Fu P, Cao S, Schmaier AH, Nayak L (2020). Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide vs. Rituximab. Front Med (Lausanne), 7, 588526.
  13. Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L (2020). The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thromb Res, 194, 101-115.
  14. Abou-Ismail MY, Citla Sridhar D, Nayak L (2020). Estrogen and thrombosis: A bench to bedside review. Thromb Res, 192, 40-51.
  15. Abou-Ismail MY, Vuyyala S, Prunty J, Schmaier AH, Nayak L (2020). Short term efficacy of recombinant porcine factor VIII in patients with factor VIII inhibitors. Haemophilia, 26(4), 601-606.
  16. Citla Sridhar D, Abou-Ismail MY, Ahuja SP (2020). Central venous catheter-related thrombosis in children and adults. Thromb Res, 187, 103-112.
  17. Abou-Ismail MY, Ogunbayo GO, Secic M, Kouides PA (2017). Outgrowing the laboratory diagnosis of type 1 von Willebrand disease: A two decade study. Am J Hematol, 93(2), 232-237.

Review

  1. Abou-Ismail MY, Kapoor S, Citla Sridhar D, Nayak L, Ahuja S (2022). Thrombotic microangiopathies: An illustrated review. [Review]. Res Pract Thromb Haemost, 6(3), e12708.

Letter

  1. Lim MY, Abou-Ismail MY (2021). Left atrial appendage occlusion for management of atrial fibrillation in persons with hemophilia. [Letter to the editor]. Thromb Res, 206, 9-13.
  2. Abou-Ismail MY, Moser KA, Smock KJ, Lim MY (2021). Vaccine-induced thrombotic thrombocytopenia following Ad26.COV2.S vaccine in a man presenting as acute venous thromboembolism. [Letter to the editor]. Am J Hematol, 96(9), E346-E349.

Other

  1. Singh B, Kanack A, Bayas A, George G, Abou-Ismail MY, Kohlhagen M, Christ M, Naumann M, Moser K, Smock K, Grazioli A, Murray D, Padmanabhan A (2021). Anti-PF4 VITT antibodies are oligoclonal and variably inhibited by heparin. United States.

News Articles

Coagulación de la sangre, COVID-19 y las vacunas

Blood Clotting, COVID-19 and Vaccines

Tres preguntas sobre las vacunas y los nuevos brotes Covid-19

Suspected VITT Blood Clotting Case After Johnson & Johnson COVID-19 Vaccination

Huntsman Cancer Institute News

Blood Clots and Cancer: A Closer Look

Site Links

  • Find an Interpreter
  • About Us
  • Academics & Research
  • Billing
  • Jobs
  • Giving
  • Maps & Directions
  • Newsroom
  • Referring Providers

Helpful Links

  • Price Estimate
  • Patient Rights & Responsibilities
  • Disclaimer
  • Privacy Statement
  • DNV GL Public Information Policy Statement
  • Non-Discrimination Policy
  • Surprise Billing Rights
  • Webmaster

Contact Us

University of Utah Health

50 North Medical Drive
Salt Lake City, UT 84132

Appointment Scheduling:
801-213-9500

Hospital Operator:
801-581-2121

En Español:
801-646-5914

  • Facebook
  • Twitter
  • Youtube
  • Instagram

University of Utah

All clinical services and programs are part of University of Utah Health Hospitals and Clinics.

Copyright © 2023 University of Utah Health